文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描用于检测头颈癌隐匿性淋巴结转移:一项系统评价和荟萃分析

FDG PET-CT for the Detection of Occult Nodal Metastases in Head and Neck Cancer: A Systematic Review and Meta-Analysis.

作者信息

Guedj Danaé, Neveü Sophie, Becker Minerva, Mermod Maxime

机构信息

Clinic of Otorhinolaryngology-Head and Neck Surgery, Department of Clinical Neurosciences, Geneva University Hospitals (HUG), 1205 Geneva, Switzerland.

Department of Pathology and Immunology, University of Geneva (UNIGE), 1206 Geneva, Switzerland.

出版信息

Cancers (Basel). 2024 Aug 24;16(17):2954. doi: 10.3390/cancers16172954.


DOI:10.3390/cancers16172954
PMID:39272812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11394031/
Abstract

Because of an estimated 20-30% prevalence of occult lymph node (LN) metastases in patients with head and neck squamous cell carcinoma (HNSCC), neck dissection is often proposed, despite its potential morbidity. In this systematic review and meta-analysis, the diagnostic performance of FDG PET-CT in detecting occult LN metastases was evaluated in patients with clinically negative necks (cN0) and in whom histopathology of a neck dissection specimen served as gold standard. Overall, 16 studies out of 2062 screened on PubMed and EMBASE fulfilled the inclusion criteria (n = 1148 patients). Seven of these sixteen studies were split into two or three studies because they contained data that could be processed distinctly in our meta-analysis. For this reason, a total of 25 studies were identified and included in the analysis (n total = 1918 patients). The overall prevalence of metastatic nodes per patient was 22.67%. The pooled sensitivity, specificity, diagnostic odds ratios, and negative predictive value (NPV) were 0.71 (95%CI: 0.66-0.75), 0.90 (95%CI: 0.84-0.93), 20.03 (95%CI: 13.51-29.70), and 0.92 (95%CI: 0.89-0.95), respectively. The main causes of inter-study heterogeneity included different reference standards (evaluation per patient, per neck side, or per neck level). The current meta-analysis showed that FDG PET-CT has a high specificity and NPV for ruling out nodal involvement in cN0 necks, but a limited sensitivity.

摘要

由于头颈部鳞状细胞癌(HNSCC)患者中隐匿性淋巴结(LN)转移的患病率估计为20%-30%,因此尽管颈部清扫术有潜在的发病率,但仍经常被建议实施。在这项系统评价和荟萃分析中,对于临床颈部阴性(cN0)且以颈部清扫标本的组织病理学作为金标准的患者,评估了FDG PET-CT在检测隐匿性LN转移方面的诊断性能。总体而言,在PubMed和EMBASE上筛选的2062项研究中有16项符合纳入标准(n = 1148例患者)。这16项研究中的7项被分为两项或三项研究,因为它们包含的数据在我们的荟萃分析中可以分别处理。因此,共确定了25项研究并纳入分析(n总计 = 1918例患者)。每位患者转移淋巴结的总体患病率为22.67%。汇总的敏感性、特异性、诊断比值比和阴性预测值(NPV)分别为0.71(95%CI:0.66-0.75)、0.90(95%CI:0.84-0.93)、20.03(95%CI:13.51-29.70)和0.92(95%CI:0.89-0.95)。研究间异质性的主要原因包括不同的参考标准(每位患者、每侧颈部或每个颈部水平的评估)。当前的荟萃分析表明,FDG PET-CT在排除cN0颈部的淋巴结受累方面具有较高的特异性和NPV,但敏感性有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/921596ac57ae/cancers-16-02954-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/4ecb4cf8b1e6/cancers-16-02954-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/fb8c22e719d9/cancers-16-02954-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/f3d3141ed3fa/cancers-16-02954-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/ec0a5265b567/cancers-16-02954-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/5f8e9a58c6d8/cancers-16-02954-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/921596ac57ae/cancers-16-02954-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/4ecb4cf8b1e6/cancers-16-02954-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/fb8c22e719d9/cancers-16-02954-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/f3d3141ed3fa/cancers-16-02954-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/ec0a5265b567/cancers-16-02954-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/5f8e9a58c6d8/cancers-16-02954-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1dd/11394031/921596ac57ae/cancers-16-02954-g006.jpg

相似文献

[1]
FDG PET-CT for the Detection of Occult Nodal Metastases in Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Cancers (Basel). 2024-8-24

[2]
Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.

Am J Otolaryngol. 2019

[3]
FDG-PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET/CT cN0.

Otolaryngol Head Neck Surg. 2021-6

[4]
Role of F-FDG PET/CT in Guiding Surgical Management of Clinically Node Negative Neck (cN0) in Carcinoma Oral Cavity.

Indian J Otolaryngol Head Neck Surg. 2023-9

[5]
The Importance of the Time Interval Between Preoperative 18F-FDG PET/CT Imaging and Neck Dissection for the Detection of Nodal Metastases in Patients with Head and Neck Squamous Cell Carcinoma.

Niger J Clin Pract. 2024-7-1

[6]
18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

J Nucl Med. 2006-5

[7]
Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities.

BMC Cancer. 2012-6-12

[8]
18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.

J Natl Cancer Inst. 2008-5-21

[9]
Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.

J Nucl Med. 2008-4

[10]
Diagnostic performance of FDG PET/MRI for cervical lymph node metastasis in patients with clinically N0 head and neck cancer.

Eur Rev Med Pharmacol Sci. 2023-5

引用本文的文献

[1]
Fibroblast activation Protein-Targeted PET/CT using [18 F]FAP-2286 for the evaluation of lung cancer: A comparative study with [18 F]FDG PET/CT.

Eur J Nucl Med Mol Imaging. 2025-8-7

[2]
Value of PET radiomic features for diagnosis and reccurence prediction of newly diagnosed oral squamous cell carcinoma.

Sci Rep. 2025-5-20

本文引用的文献

[1]
ESR Bridges: imaging and treatment of extranodal spread in head and neck cancer-a multidisciplinary view.

Eur Radiol. 2025-2

[2]
Diagnostic Accuracy of Up-Front PET/CT and MRI for Detecting Cervical Lymph Node Metastases in T1-T2 Oral Cavity Cancer-A Prospective Cohort Study.

Diagnostics (Basel). 2023-11-9

[3]
PET/MR Imaging in Head and Neck Cancer.

Magn Reson Imaging Clin N Am. 2023-11

[4]
Role of F-FDG PET/CT in Guiding Surgical Management of Clinically Node Negative Neck (cN0) in Carcinoma Oral Cavity.

Indian J Otolaryngol Head Neck Surg. 2023-9

[5]
Radiomics-based machine learning for the diagnosis of lymph node metastases in patients with head and neck cancer: Systematic review.

Head Neck. 2023-2

[6]
Detection of distant metastases and distant second primary cancers in head and neck squamous cell carcinoma: comparison of [F]FDG PET/MRI and [F]FDG PET/CT.

Insights Imaging. 2022-7-28

[7]
A new combined index of SUVmax of lymph node in PET / CT by a weighting coefficient plus its maximum minor axis in CECT to evaluate occult lymph node metastasis in clinical N0 patients with tongue cancer.

J Med Invest. 2021

[8]
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

BMJ. 2021-3-29

[9]
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021-5

[10]
Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal Cancer.

J Clin Oncol. 2020-12-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索